DeepMind AlphaGenome 2 Reads DNA Cell by Cell to Pinpoint Disease Variants
Google DeepMind announced AlphaGenome 2 on Wednesday, November 11, a DNA model that reads genetic variants the way they actually work in the body: one cell type at a time. Instead of averaging a variant’s effect across a whole tissue, the new model predicts how a change in DNA alters gene activity inside specific human cells. DeepMind trained it on more than 107 million individual cell profiles across 68 tissues, and it is available now for non-commercial research through the AlphaGenome API. ...